Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR -Mutant Metastatic Non–Small-Cell Lung Cancer (RELAY): Phase Ib Results

詳細情報 詳細情報について

• CRID

  1360285707041524352

• DOI

  10.1016/j.cllc.2017.11.003

• ISSN

  15257304

• Web Site

  https://api.elsevier.com/content/article/PII:S1525730417303157?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1525730417303157?httpAccept=text/plain

• データソース種別

  • Crossref
  • KAKEN